Oral docetaxel plus encequidar - a phase 1 clinical trial.
Wang D, Hung N, Hung T, Eden K, Chan WK, Kwan R, Qin A, Chang C, Duffull S, Glue P, Jackson C.
Wang D, et al. Among authors: jackson c.
Cancer Chemother Pharmacol. 2024 May 30. doi: 10.1007/s00280-024-04674-4. Online ahead of print.
Cancer Chemother Pharmacol. 2024.
PMID: 38814342